Anastasia Samarkina

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Luigi Mazzeo, Soumitra Ghosh, Emery Di Cicco, Jovan Isma, Daniele Tavernari, Anastasia Samarkina, Paola Ostano, Markus Kirolos Youssef, Christian Simon, Gian Paolo Dotto
ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation. Nature communications 15 (1) (2024)
Luigi Mazzeo, Soumitra Ghosh, Emery Di Cicco, Jovan Isma, Daniele Tavernari, Anastasia Samarkina, Paola Ostano, Markus Kirolos Youssef, Christian Simon, Gian Paolo Dotto
ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation. Nature communications 15 (1) (2024)
Luigi Mazzeo, Soumitra Ghosh, Emery Di Cicco, Jovan Isma, Daniele Tavernari, Anastasia Samarkina, Paola Ostano, Markus Kirolos Youssef, Christian Simon, Gian Paolo Dotto
ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation. Nature communications 15 (1) (2024)
Luigi Mazzeo, Soumitra Ghosh, Emery Di Cicco, Jovan Isma, Daniele Tavernari, Anastasia Samarkina, Paola Ostano, Markus Kirolos Youssef, Christian Simon, Gian Paolo Dotto
ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation. Nature communications 15 (1) (2024)
Anastasia Samarkina, Markus Kirolos Youssef, Paola Ostano, Soumitra Ghosh, Min Ma, Beatrice Tassone, Tatiana Proust, Giovanna Chiorino, Mitchell P Levesque, Sandro Goruppi, Gian Paolo Dotto
Androgen receptor is a determinant of melanoma targeted drug resistance. Nature communications 14 (1) (2023)
Rajasekharan Somasundaram, Thomas Connelly, Robin Choi, Hyeree Choi, Anastasia Samarkina, Ling Li, Elizabeth Gregorio, Yeqing Chen, Rohit Thakur, Mohamed Abdel-Mohsen, Marilda Beqiri, Meaghan Kiernan, Michela Perego, Fang Wang, Min Xiao, Patricia Brafford, Xue Yang, Xiaowei Xu, Anthony Secreto, Gwenn Danet-Desnoyers, Daniel Traum, Klaus H Kaestner, Alexander C Huang, Denitsa Hristova, Joshua X Wang, Mizuho Fukunaga-Kalabis, Clemens Krepler, Fang Ping-Chen, Xiangyang Zhou, Alexis Gutierrez, Vito W Rebecca, Prashanthi Vonteddu, Farokh Dotiwala, Shashi Bala, Sonali Majumdar, Harsh Dweep, Jayamanna Wickramasinghe, Andrew V Kossenkov, Jorge Reyes-Arbujas, Kenisha Santiago, Tran Nguyen, Johannes Griss, Frederick Keeney, James Hayden, Brian J Gavin, David B Weiner, Luis J Montaner, Jingjing Liu, Lukas Peiffer, Jürgen Becker, Elizabeth M Burton, Michael A Davies, Michael T Tetzlaff, Kar Muthumani, Jennifer A Wargo, Dmitry I Gabrilovich, Meenhard Herlyn
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. Nature communications 12 (1) (2021)

Anastasia Samarkina.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anastasia Samarkina